Hope in the Pipeline

Big Updates at Preferred Research Partners

Discover exciting new developments at Preferred Research Partners, including our new IV infusion suite, expanded clinical trial capabilities, and the introduction of Dr. David Weed to the team.

Understanding IBD & Expanding Access for Spanish-Speaking Communities

Have you or a loved one experienced ongoing abdominal pain, fatigue, or digestive issues like diarrhea or loss of appetite? You may be living with one of the lifelong conditions known as Inflammatory Bowel Disease (IBD), which includes Crohn’s disease and ulcerative colitis. In this episode of Hope in the Pipeline, Dr. Paul Wylie, Medical Director of Preferred Research Partners in Little Rock, Arkansas, welcomes Dr. Natasa Jensen to discuss what causes IBD, its symptoms, treatment options, and the importance of early diagnosis and clinical research. You’ll also meet Erik Guzman, a bilingual research coordinator, who shares his inspiring story and efforts to make clinical trials more accessible to the Spanish-speaking community. He discusses barriers to participation, the need for diversity in medical research, and how Preferred Research Partners is building trust and partnerships across Arkansas to create healthier, more informed communities.

What Does Signing Up For a Gastroparesis Study Look Like? 👀

For this episode of Hope in the Pipeline, Dr. Wylie is joined by one of our Clinical Research Coordinators, Jessica Watson. They talk about gastroparesis clinical trials, and Jessica explains what a research trial looks like. Interested in learning more? Visit our website for more information about clinical research trials: www.preferredresearchpartners.com [http://www.preferredresearchpartners.com/]

Living With Gastroparesis | New Hope Through Research 🙏

Gastroparesis affects about 5 million people in the U.S. — causing nausea, stomach pain, bloating, and more. In this episode of Hope in the Pipeline, Dr. Paul Wy shares how clinical trials are leading the way to better treatments and why participation matters. Together, we can bring hope to millions.

Understanding Narcolepsy & Hypersomnolence Disorders Part 3

Welcome to the third part of our Hope in the Pipeline series on hypersomnolence disorders. In this episode, we dive deep into:   🔹 Medications used to treat narcolepsy – from older stimulants to newer, longer-lasting options 🔹 The role of antidepressants and sodium oxybate in managing symptoms like cataplexy 🔹 Key differences between narcolepsy and idiopathic hypersomnia (IH) 🔹 Current treatment options for IH and why diagnosis can be so challenging 🔹 Exciting ongoing clinical research at Preferred Research Partners, including a new potential therapy targeting narcolepsy and IH